Biotechnology (49) | Share Agreements (49)
Browse by Company
-
Allogene Therapeutics, Inc. (1)
-
Amgen Inc. (2)
-
AmpliPhi Biosciences Corp (1)
-
Aptose Biosciences Inc. (1)
-
ARYA Sciences Acquisition Corp II (1)
-
Athenex, Inc. (2)
-
BeiGene, Ltd. (6)
-
Benitec Biopharma Inc. (1)
-
BICYCLE THERAPEUTICS Ltd (6)
-
Biohaven Pharmaceutical Holding Co Ltd. (2)
-
bluebird bio, Inc. (1)
-
Chardan Healthcare Acquisition Corp. (1)
-
CYTORI THERAPEUTICS, INC. (1)
-
Dicerna Pharmaceuticals Inc (2)
-
GeoVax Labs, Inc. (1)
-
InMed Pharmaceuticals Inc. (1)
-
Invitae Corp (1)
-
Kiniksa Pharmaceuticals, Ltd. (6)
-
NOVAVAX INC (1)
-
Opko Health, Inc. (1)
-
PDL BIOPHARMA, INC. (1)
-
PharmaCyte Biotech, Inc. (1)
-
SPHERIX INC (1)
-
Sunshine Biopharma, Inc (1)
-
TYME TECHNOLOGIES, INC. (1)
-
Xenetic Biosciences, Inc. (5)
Recent Contracts
-
Offering Document under the 2018 Employee Share Purchase Plan (effective July 1, 2019)
(Kiniksa Pharmaceuticals, Ltd., Filed With SEC on February 25, 2021)
-
Offering Document under the 2018 Employee Share Purchase Plan (effective January 1, 2021)
(Kiniksa Pharmaceuticals, Ltd., Filed With SEC on February 25, 2021)
-
Restricted Share Agreement, dated as of September 18, 2015, by and between Kiniksa Pharmaceuticals, Ltd. and Thomas Beetham
(Kiniksa Pharmaceuticals, Ltd., Filed With SEC on February 25, 2021)
-
Share Purchase Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited
(Allogene Therapeutics, Inc., Filed With SEC on February 25, 2021)
-
Series B Preferred Share Purchase Agreement by and
(Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on November 9, 2020)
-
Restated Amendment No. 2 to Share Purchase Agreement, dated September 24, 2020, by and among BeiGene, Ltd. and Amgen Inc
(Amgen Inc., Filed With SEC on October 29, 2020)
-
Restated Amendment No. 2 to Share Purchase Agreement, dated September 2
(BeiGene, Ltd., Filed With SEC on September 24, 2020)
-
Form of Stock Certificate representing the Companys Common Stock, par value $0.001 per share after the reverse stock split is effected
(GeoVax Labs, Inc., Filed With SEC on August 26, 2020)
-
Form of Option Award Agreement under the Benitec Officers and Employees Share Option Plan
(Benitec Biopharma Inc., Filed With SEC on August 14, 2020)
-
Share Purchase Agreement, dated May 27, 2020, by and among the Company (solely as guarantor), Novavax AB, De Bilt Holdings B.V., Poonawalla Science Park B.V., Bilthoven...
(NOVAVAX INC, Filed With SEC on August 10, 2020)